TrialCPT: pharmacometrics & systems pharmacology2026

Talazoparib Formulation Bridging in Cancer Patients-Challenges and the Critical Role of Model-Informed Drug Development in Approval Despite Failed Bioequivalence.

Diane Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.